Photo courtesy of DTx Pharma.
In May 2020, the biotech expanded its footprint into a new 14,000 square foot lab and office space in Sorrento Valley.
San Diego-based DTx Pharma, a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, has raised a $100 million in Series B financing…
Take 1 minute to subscribe and you’ll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know
Yours for only $99